LIMS1: A Potential Drug Target and Biomarker for Renal Carcinoma

Target Name: LIMS1

NCBI ID: G3987

LIMS1

LIMS1: A Potential Drug Target and Biomarker for Renal Carcinoma

Renal carcinoma is a type of cancer that affects the kidneys, and it is one of the most common cancers that affects this organ. According to the American Cancer Society, the incidence of renal carcinoma in the United States has increased by 45% since the 1990s, and it is expected to reach 6,120 deaths per year by 2024. Therefore, identifying potential drug targets and biomarkers for this cancer is crucial for improving treatment outcomes.

LIMS1 (Renal carcinoma antigen NY-REN-48) is a protein that is expressed in human renal tissues, including those of cancerous origin. It has been identified as a potential drug target for renal carcinoma due to its expression in high-risk and recurrent renal carcinomas, as well as its potential to serve as a biomarker for this disease. In this article, we will explore the biology of LIMS1 and its potential as a drug target and biomarker for renal carcinoma.

Biochemistry and Expression

LIMS1 is a 21-kDa transmembrane protein that is expressed in various tissues, including the kidney, lung, heart, and brain. It is predominantly expressed in the proximal tubules of the kidney, where it is involved in the regulation of water and electrolyte balance. LIMS1 has been shown to be expressed in a variety of renal epithelial and stromal cells, including those derived from normal tissue and cancerous tissue.

In addition to its expression in renal tissues, LIMS1 has also been shown to be expressed in various other tissues and cells, including fetal liver, pancreatic cancer, and colorectal cancer. This suggests that LIMS1 may be a promising biomarker for renal carcinoma, and that it may have relevance for the development of new diagnostic tests and therapies.

Function and Interaction

The function of LIMS1 is not well understood, but it is thought to play a role in the regulation of water and electrolyte balance in various tissues. It is involved in the regulation of the levels of water in and out of cells, as well as the regulation of electrolytes, such as sodium and potassium.

In addition to its role in cell signaling, LIMS1 may also be involved in the regulation of inflammation and fibrosis. Studies have shown that LIMS1 is involved in the regulation of inflammation in various tissues, including the kidney. Additionally, LIMS1 has been shown to be involved in the regulation of fibrosis, a process that is associated with the development of various diseases, including cancer.

Drug Target Potential

The potential drug target for LIMS1 is based on its expression in various tissues and its involvement in the regulation of cell signaling, water and electrolyte balance, and inflammation. Several potential drug targets have been identified for LIMS1, including the inhibition of the LIMS1-associated protein (LAP), which has been shown to promote the growth and survival of cancer cells, as well as the inhibition of the LIMS1-associated protein (LIMS1), which has been shown to inhibit the growth and survival of cancer cells.

Another potential drug target for LIMS1 is the inhibition of the LIMS1-associated protein (LAP), which has been shown to promote the growth and survival of cancer cells.

Biomarker Potential

LIMS1 has the potential to serve as a biomarker for renal carcinoma due to its expression in various tissues, including those of cancerous origin. The expression of LIMS1 in cancerous tissue may be an indicator of the presence and extent of cancer, and may have implications for the diagnosis and prognosis of renal carcinoma.

In addition to its potential as a biomarker, LIMS1 may also have implications for the development of new diagnostic tests for renal carcinoma. The expression of LIMS1 in various tissues, including those of cancerous origin, suggests that it may be an

Protein Name: LIM Zinc Finger Domain Containing 1

Functions: Adapter protein in a cytoplasmic complex linking beta-integrins to the actin cytoskeleton, bridges the complex to cell surface receptor tyrosine kinases and growth factor receptors. Involved in the regulation of cell survival, cell proliferation and cell differentiation

The "LIMS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LIMS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets